Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin discolouration, Tremor, Vaccination site reaction
Clinical narrative: red 1" painful circular area developed / Near but not including actual injection site; red 1" painful circular area developed / Near but not including actual injection site; red 1" painful circular area developed / Near but not including actual injection site; initial red area turned purple and lighter red area; Painful and itchy; Painful and itchy; Lymphadenopathy in armpit; shaking; chills; booster dose; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Nov2021 11:15 (Lot number: FJ1620) at the age of 63 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Sulfa" (unspecified if ongoing). Concomitant medication(s) included: CALCIUM. Past drug history included: Amoxycillin for Known allergies: Amoxycillin. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6207, Location of injection: Arm Left), administration date: 31Mar2021, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6199, Location of injection: Arm Left), administration date: 10Mar2021, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 30Nov2021 11:15, outcome "unknown", described as "booster dose"; ERYTHEMA (non-serious), PAIN (non-serious), VACCINATION SITE REACTION (non-serious) all with onset 01Dec2021, outcome "not recovered" and all described as "red 1" painful circular area developed / Near but not including actual injection site"; SKIN DISCOLOURATION (non-serious) with onset 01Dec2021, outcome "not recovered", described as "initial red area turned purple and lighter red area"; PAIN (non-serious), PRURITUS (non-serious) all with onset 01Dec2021, outcome "not recovered" and all described as "Painful and itchy"; LYMPHADENOPATHY (non-serious) with onset 01Dec2021, outcome "not recovered", described as "Lymphadenopathy in armpit"; TREMOR (non-serious) with onset 01Dec2021, outcome "not recovered", described as "shaking"; CHILLS (non-serious) with onset 01Dec2021, outcome "not recovered", described as "chills". The events "red 1" painful circular area developed / near but not including actual injection site", "red 1" painful circular area developed / near but not including actual injection site", "red 1" painful circular area developed / near but not including actual injection site", "initial red area turned purple and lighter red area", "painful and itchy", "painful and itchy", "lymphadenopathy in armpit", "shaking" and "chills" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of erythema, pain, vaccination site reaction, skin discolouration, pain, pruritus, lymphadenopathy, tremor, chills.  Additional information: No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.